Laser and light therapies for the treatment of necrobiosis lipoidica
Lasers in Medical Science · 2021-04 · 36 (3) · 497-506
DOI: 10.1007/s10103-020-03147-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lasers in Medical Science, online erschienen am 24.09.2020. Verfasst von Ali Rajabi-Estarabadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1150 NW 14th St., Miami, FL, 33136,…. Hauptthemen laut MEDLINE: Laser Therapy, Phototherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Necrobiosis lipoidica (NL) is a rare, inflammatory granulomatous skin disorder involving collagen degeneration. In recent years, several light and laser therapies have been proposed and used in the treatment of NL with variable outcomes. The aim of the study was to investigate the efficacy and safety of lasers and light therapies for the treatment of NL. A review of PubMed was conducted to search for studies using laser and light therapies for the treatment of NL. Articles that employed a combination of treatment modalities were excluded. Twenty-four studies were reviewed. Light and laser therapies used in these studies included CO2 laser, pulsed dye laser, methyl aminolevulinate (MAL)-photodynamic therapy (PDT), aminolevulinic acid (ALA)-PDT, ultraviolet A1 (UVA1) phototherapy, and psoralen plus ultraviolet-A (PUVA). PUVA was identified as the modality with the most available evidence (7 studies), followed by MAL-PDT and ALA-PDT (5 studies each), pulsed dye laser and UVA1 (3 studies each), and lastly CO2 laser (2 studies). Most modalities demonstrated variable efficacies and side effects with the exception of PDL, which consistently showed successful outcomes. Multiple dermatologic light and laser therapies have been investigated for the treatment of NL, including PUVA, ALA-PDT, MAL-PDT, pulsed dye laser, UVA1, and CO2 laser. However, a clear consensus on the preferred treatment is yet to be addressed. Each treatment option demonstrates both advantages and disadvantages that should be discussed with patients when selecting the treatment modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1150 NW 14th St., Miami, FL, 33136, USA. arajabi@med.miami.edu.
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1150 NW 14th St., Miami, FL, 33136, USA.
Zitieren
APA
Rajabi-Estarabadi, A., Aickara, D. J., Hirsch, M., Williams, N. M., Maranda, E. L., & Van Badiavas, E. (2021). Laser and light therapies for the treatment of necrobiosis lipoidica. Lasers in Medical Science, 36(3), 497-506. https://doi.org/10.1007/s10103-020-03147-3
Vancouver
Rajabi-Estarabadi A, Aickara DJ, Hirsch M, Williams NM, Maranda EL, Van Badiavas E. Laser and light therapies for the treatment of necrobiosis lipoidica. Lasers in Medical Science. 2021;36(3):497-506. doi:10.1007/s10103-020-03147-3
BibTeX
@article{RajabiEstarabadi2021,
author = {Rajabi-Estarabadi, Ali and Aickara, Divya J and Hirsch, Melanie and Williams, Natalie M and Maranda, Eric L and Van Badiavas, Evangelos},
title = {Laser and light therapies for the treatment of necrobiosis lipoidica},
journal = {Lasers in Medical Science},
year = {2021},
volume = {36},
number = {3},
pages = {497--506},
doi = {10.1007/s10103-020-03147-3}
}
EUVIMED